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Matrix metalloproteinases (MMPs) are zinc (Zn2þ) and calcium (Ca2þ) dependant endopeptidases,
capable of degradation of numerous components of the extracellular matrix. Cadmium (Cd2þ) is a well
known environmental contaminant which could impair the activity of MMPs. In this sense, this study
was conducted to evaluate if Cd2þ intake inhibits these endopeptidases activities at the rat prostate and
testicles and if it directly inhibits the activity of MMP2 and MMP9 at gelatinolytic assays when present in
the incubation buffer. To investigate this hypothesis, Wistar rats (5 weeks old), were given tap water
(untreated, n ¼ 9), or 15 ppm CdCl2 diluted in drinking water, during 10 weeks (n ¼ 9) and 20 weeks
(n ¼ 9). The animals were euthanized and their ventral prostate, dorsal prostate, and testicles were
removed. These tissue samples were processed for protein extraction and subjected to gelatin zymog-
raphy evaluation. Additionally, we performed an experiment of gelatin zymography in which 5 mM or
2 mM cadmium chloride (CdCl2) was directly dissolved at the incubation buffer, using the prostatic tissue
samples from untreated animals that exhibited the highest MMP2 and MMP9 activities in the previous
experiment. We have found that CdCl2 intake in the drinking water led to the inhibition of 35% and 30%
of MMP2 and MMP9 (p < 0.05) at the ventral prostate and testis, respectively, in Cd2þ treated animals
when compared to controls. Moreover, the activities of the referred enzymes were 80% and 100%
inhibited by 5 mM and 2 mM of CdCl2, respectively, even in the presence of 10 mM of CaCl2 within the
incubation buffer solution. These important ﬁndings demonstrate that environmental cadmium
contamination may deregulate the natural balance in the extracellular matrix turnover, through MMPs
downregulation, which could contribute to the toxic effects observed in prostatic and testicular tissue
after its exposure.
© 2015 Elsevier Inc. All rights reserved.1. Introduction
Matrixmetalloproteinases (MMPs) compose a family of zinc and
calcium dependant endopeptidases responsible for the remodeling
and degradation of extracellular matrix (ECM) proteins, such as
collagen, elastin, laminin, ﬁbronectin, and proteoglycans [1]. These
enzymes are produced as latent precursors, named zymogens or
pre-MMPs, which require prior activation to be able to break theNESP, Institute of Biosciences,
District of Rubi~ao Júnior S/N,
o).ECM components [2e4]. MMPs expression can be evaluated via
different techniques; however, the gelatin zymography assay al-
lows the determination of both active and latent forms of MMPs,
mainly for MMP2 and MMP9 [5].
The expression/activity of MMP2 and MMP9 is directly corre-
lated with ECM remodeling, in which an unbalanced activity may
contribute to several diseases in different tissues such as rheuma-
toid arthritis, osteoarthritis, cardiovascular dysfunction, and cancer
[6e8]. Therefore, any substance that has the ability to deregulate
the homeostasis of the MMP activity may be potentially harmful.
Interestingly, the MMPs activity is tightly regulated by divalent ions
concentration, mainly Zn2þ and Ca2þ. Previous researchers re-
ported that other metals, such as Sr2þ, Co2þ, Br2þ, Mn2þ, and Mg2þ,
are able to interfere with the activity of these enzymes at
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zinc directly inhibited 25 kDa and 43 kDa enamel matrix pro-
teinases in vitro activities when dissolved at the incubation buffer
of gelatin zymography assays, even in low concentrations such as
110 mM [10].
Although cadmium has a well documented toxic and carcino-
genic effect on the male reproductive system [11], little is known if
it has also the potential to unbalance the normal activity proﬁle of
these important enzymes for prostate physiology [12,13]. Thus, this
studywas conducted to narrow this gap, by evaluating the effects of
cadmium on the gelatinolytic activities of MMP2 and MMP9, in the
rat prostate and testis.
2. Material and methods
2.1. Animals and treatments
Wistar rats were provided by the Central Stock breeder of S~ao
Paulo State University (UNESP, Botucatu, SP, Brazil), andmaintained
in cages (3 rats/cage) under controlled temperature (20e22 C) and
lighting conditions. The animals were fed a standard pellet diet and
water ad libitum. Experimental protocols met the “Guidelines of
Animal Experimentation” approved by the Commission of Ethics in
Animal Experimentation (Protocol number 139/2009-CEEA) at the
Institute of Biosciences, UNESP. After 7 days of acclimatization, theFig. 1. Cadmium effects on the activity of MMP2 and MMP9 of animals exposed to Cd contam
(B), and dorsal prostate (C) tissue extracts of untreated animals (Ct) and animals exposed
MMP9 were loaded as positive controls (Std). Under control conditions, in the testis (A), i
signiﬁcant inhibition of this activity by 30% in the 20 week-treated animals (as shown in
extracts (B), it is possible to observe high activity of three bands of MMP2 (latent, intermedia
a signiﬁcant decrease in the activity of these enzymes, for both 10 and 20 week-treated anima
and MMP2 were observed (81 and 59 kDa, respectively). A signiﬁcant downregulation of the
(30%). (*) Statistically signiﬁcant difference from control conditions with p < 0.01.animals were randomized into three experimental groups. The
control rats (untreated) received tap water (n ¼ 9), and the Cd
treated groups were exposed to 15 ppm of CdCl2 (Sigma™) which
was done over 10 weeks (n ¼ 9) or 20 weeks (n ¼ 9). This con-
centration was chosen after a revision of the current available data
and is reported to be equivalent to non-carcinogenic exposure [14].
2.2. Tissue processing and gelatin zymography
After the exposure period, the animal's ventral and dorsal
prostatic lobes were collected, along with the testis. All tissue
specimens were immediately frozen in liquid nitrogen (196 C).
Protein extraction was conducted as described [15]. Brieﬂy, 30 mg
of tissuewere processedwith a Polytron homogenizer in 0.1mL of a
50 mM Tris-HCl solution, pH 7.5, supplemented with 0.25% Triton
X-100,10mMCaCl2, and protease cocktail inhibitor (Sigma™). After
a 4 C/20 min/14,000 rpm centrifugation, the supernatant was
collected and subjected to protein quantiﬁcation using the Bradford
technique [15].
Gelatin zymography was performed as previously described
[8,12] with modiﬁcations. Brieﬂy, 30 mg of protein obtained from
untreated and treated tissue extracts were loaded in 8% poly-
acrylamide gels co-polymerized with 0.1% gelatin (Merck™) acting
as the substrate for the enzymes. Positive controls e puriﬁed hu-
man MMP2 (20 ng) and MMP9 (30 pg) (Calbiochem™) ewere alsoinated drinking water. Representative gelatin zymography of testis (A), ventral prostate
to cadmium during 10 (Cd10) and 20 (Cd20) weeks. Recombinant human MMP2 and
t is possible to observe the active form of MMP2 (59 kDa). Cadmium exposure led to
the fold-change graphic). Also, under control conditions, in the ventral prostate lobe
te and active forms; 72 kDa/67 kDa/59 kDa, respectively). Cadmium exposure also led to
ls (35% and 40%, respectively). In the dorsal prostate (C), only the active forms of MMP9
activity of these enzymes was also observed in the 20 week cadmium treated animals
Fig. 2. Cadmium direct effects on the gelatinolytic activity of MMP2 and MMP9 when
added to the incubation buffer. Gelatin zymography assay of tissue extracts of the
ventral prostate (A) and dorsal prostate (B). Samples from tissue extracts (30 mg) of
untreated animals (n ¼ 3) with high gelatinolytic activities were subjected to the assay
with or without cadmium (as cadmium chloride e CdCl2) dissolved at the standard
incubation buffer. Two concentrations were employed (5 mM or 2 mM CdCl2). Under
the standard incubation buffer (Ct), high MMP2 and MMP9 activities are observed. The
lower concentration of 5 mM induces 80% inhibition of activity. Cadmium chloride at
2 mM totally inhibits the activities of these enzymes: no clear bands are visualized
(arrow).
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twice in 2.5% Triton X-100 to remove sodium dodecyl sulfate and
further washed in 50 mM Tris-HCl pH 8.0. Gels were incubated for
the following 20 h in an activation buffer (50 mM TriseHCl sup-
plemented with 5 mM CaCl2). Gels were stained with Coomassie
brilliant blue R-250 and de-stained with 20% methanol and 10%
acetic acid in distilled water until the clear bands had been
visualized.
In addition, protein extracts from the ventral and dorsolateral
prostates from untreated animals that exhibited the highest MMP2
and MMP9 activities were loaded in triplicate, in 3 gels, and sub-
jected to gelatin zymography as described. One of the gels was
incubated with the regular activation buffer, while the other two
were incubated with the same buffer plus 5 mM CdCl2 or 2 mM
CdCl2, to investigate the direct ability of cadmium to inhibit MMPs
activities.
2.3. Image acquisition, quantiﬁcation and statistical analysis
The gels were analyzed with the Image Quant350 equipment
and the activities of the visualized bands were quantiﬁed using the
ImageJ™ free software. The integrated optical density (IOD) was
measured and the data was analyzed with INSTAT™ software using
an ANOVA (p < 0.05) to compare the different treatments, with a
post-test of Tuckey-Kramer. Values were calculated as the
mean± SD of the totality of IODs for the pro- and active forms of the
MMP2 and MMP9 enzymes. Finally, a fold-change graphic was
made by dividing themeans of the values for the treated animals by
the mean of the values for the untreated animals.
3. Results
Animals that were exposed to cadmium in their drinking water
presented alterations in the activity of MMP2 and MMP9 within
their tissue extracts. Testis extracts from 20 week-treated animals
exhibited a signiﬁcant reduction of 30% in the gelatinolytic activity
of the active form of MMP2, when compared to untreated animals
(Fig.1A). Ventral prostatic lobe tissue extracts from10 and 20week-
treated animals exhibited a signiﬁcant reduction (35% and 40%,
respectively) of the activity of the three different forms (latent,
intermediate and active) of MMP2 (72, 67, and 59 kDa, respec-
tively). No MMP9 activity was detected for this lobe (Fig. 1B). The
dorsal prostatic lobe tissue extracts from 10 and 20 weeks-treated
animals presented reduction in the activity of the active forms of
MMP9 and MMP2, signiﬁcant only for 20 week-treated animals
(30%) (Fig. 1C).
The presence of 5 mM or 2 mM of CdCl2 in the zymography in-
cubation buffer was able to inhibit 80% and 100%, respectively, of
the MMP2 and MMP9 activities in the ventral and dorsal prostates
extracts from untreated animals (Fig. 2).
4. Discussion
Every day we are exposed to cadmium, an important environ-
mental contaminant present in devices such as batteries of elec-
tronic hardware. Such exposure also results from the emission of
cadmium in the atmosphere, as a result of processes such as the
steel industry, waste incineration [15e17], as well as contaminants
found in drinking water, food, and in tobacco smoke [15,17]. Taking
into account the signiﬁcant exposure to this agent, especially to the
prostate, studies that enlighten the mechanisms by which this
metal interferes with cellular homeostasis are required for better
assessment of the real exposure risks.
Although it's well accepted that cadmium exerts a real carci-
nogenic stimulus to the prostate gland [14,15], little is known aboutits induced effects upon the expression/activity of MMPs in this
gland. Given the well documented relationship between poor
prognosis prostate tumors and high expression ofMMPs [18,19], we
aimed to investigate whether cadmium could stimulate or inhibit
the activity of these important endopeptidases. Our study is the
ﬁrst to describe that 5 mM CdCl2 inhibits the MMP2 and MMP9
gelatinolytic activity in vitro, even in the presence of 5 mM of CaCl2.
It is known that the prostate is a major site for cadmium accu-
mulation, after the liver and kidneys [20]. Animals chronically
exposed to cadmium in drinking water also exhibited decreased
MMP2 and MMP9 in their prostatic and testis tissues, reinforcing
the relationship between cadmium consumption and accumulation
in these organs. These enzymes have been reported to be poten-
tially inhibited by Zn2þ and Cu2þ, at low concentrations of 100 mM
[21] and also to higher concentrations (2 mM) of Zn2þ, Co2þ, Br2þ,
Mn2þ, Mg2þ [9]. It is believed that these divalent ions exert their
inhibitory effects by conformational changes in the catalytic
domain of these enzymes [22]. Besides the potential effects on
prostate carcinogenesis, we have demonstrated that cadmium also
downregulated the activity of MMPs in the testicles, which could
contribute to an imbalance in reproductive success, given the
important role of these peptidases on themotility of spermatozoids
[9].
It is well established that short-It is well established that short-
term acute cadmium exposure by nebulization induces a remark-
able and transient inﬂammation of the lung tissue, in which is
followed by a transient increase of local MMPs activities due to
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contrast, the dose and the route of administration of cadmium used
in our study and in previous studies [14,20] does not induce sig-
niﬁcant inﬂammatory response in the prostate and testis, pointing
to the important differences in the cadmium direct effects onMMPs
activities and indirect on tissue levels of MMPs expression.
In conclusion, our results highlight that cadmium, even in a
thousand times lower concentration than calcium, is able to
directly inhibit the activities of both MMP2 and MMP9 when
diluted on the zymography assay. Moreover, the toxic effects of this
metal on the prostate and testis may be also related to an impair-
ment of MMPs activities in these tissues, suggesting that further
investigation about cadmium toxicity should take into account its
impact on MMPs.Conﬂict of interest
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